J. Veys Pharma SRL
J. Veys Pharma reported total assets of 94,994 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Mar 2026).
The score of J. Veys Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
J. Veys Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Mar 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
J. Veys Pharma's financial analysis
- Solvency85.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of J. Veys Pharma
J. Veys Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.880.858
- VAT number
- BE0804880858
- Peppol
- Registered · 0208:0804880858 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Aug 2023
- Registered office
- 8790 Waregem
- Latest accounts
- 2025 · filed on 04 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
J. Veys Pharma (SRL) has been based in Waregem since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,149 € and equity of 81,597 €; its revenue is not published. Its solvency stands at 85.9%, above the median of its sector (44.2%).
Companies similar to J. Veys Pharma
Companies in the same business, of comparable size and area, outside its group.
- Farmarie Retail sale of pharmaceutical products Destelbergen · balance sheet 94,659 €
- Arthur Pharma Retail sale of pharmaceutical products Zaventem · balance sheet 93,827 €
- S.G. Pharma Retail sale of pharmaceutical products Aalst · balance sheet 93,620 €
- APVL Retail sale of pharmaceutical products Bornem · balance sheet 96,516 €
- Stelieco Retail sale of pharmaceutical products Brasschaat · balance sheet 96,802 €
- Joeri MAX Retail sale of pharmaceutical products Peer · balance sheet 92,467 €
- OSLM Retail sale of pharmaceutical products Charleroi · balance sheet 92,150 €
- Societe Pharmaceutique DE Gestion Retail sale of pharmaceutical products Ixelles · balance sheet 86,711 €
Frequently asked questions about J. Veys Pharma
What is the revenue of J. Veys Pharma?
J. Veys Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of J. Veys Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0804880858 for J. Veys Pharma, if the company is VAT-registered. Its company number (CBE) is 0804.880.858.
Where is the registered office of J. Veys Pharma?
According to the CBE register, the registered office of J. Veys Pharma is in 8790 Waregem.
What is the equity of J. Veys Pharma?
At the close of the 2025 financial year, the equity of J. Veys Pharma amounts to 81,597 €, a solvency of 85.9% of total assets.
Who manages J. Veys Pharma?
The register lists 1 active mandates at J. Veys Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of J. Veys Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →